The role of photosensitized macrophages in photodynamic therapy

Oncology Reports

Volumn 26, Issue 1, 2011, Pages 275-280

  Kawczyk Krupka, Aleksandra ^a   Czuba, Zenon ^b   Szliszka, Ewelina ^b   Król, Wojciech ^b   Sieroń, Aleksander ^a  

^a UNIVERSITY OF SILESIA   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

aminolevulinic acid; Chemiluminescence; IL 1 ; J 774A.1 cells; NF B p50 p65; NO; Photodynamic therapy; ROI; TNF

Indexed keywords

AMINOLEVULINIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; NITRIC OXIDE; PROTEIN P50; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL ACTIVITY; CELL VIABILITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY TEST; IMMUNE RESPONSE; MACROPHAGE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL NUCLEUS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; IMMUNE SYSTEM; INTERLEUKIN-1BETA; MACROPHAGES; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955806972     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1262     Document Type: Article

References (36)

1. Polverini PJ, Cotran RS, Gimbron MA Jr and Unanue ER: Actirated macrophages induce vascular proliferation. Nature 269: 804-806, 1977. (Pubitemid 8208827)
2. Dougherty TJ: A brief history of clinical photo dynamic therapy development at Roswell Park Cancer Institute. J Clin Laser Med Surg 14: 219-221, 1996.
3. Tyrrell JS, Campbell SM and Curnow A: The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome. Lasers Surg Med 42: 613-619, 2010.
4. Castano AP, Mroz P and Hamblin MR: Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6: 535-545, 2006.
5. Normann SJ: Macrophage infiltration and tumor progression. Cancer Metastasis Rev 4: 277-291, 1985.
6. Gollnick SO, Evans SS, Baumann H, Owczarczak B, Maier PL, Vaughan WC, Wang E, Unger E and Henderson BW: Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 88: 1772-1779, 2003. (Pubitemid 36760423)
7. Reeves KJ, Reed MW and Brown NJ: The role of nitric oxide in the treatment of tumours with aminolaevulinic acid-induced photodynamic therapy. J Photochem Photobiol B 101: 224-232, 2010.
8. Halliwell B and Cross CE: Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 102: 5-12, 1994
9. Dias Ribeiro AP, Pavarina AC, Trindade FZ, Inada NM, Bagnato VS and de Souza Costa CA: Photodynamic therapy associating Photogem® and blue LED on L929 and MDPC-23. Cell Biol Int 34: 343-351, 2010.
10. Park JH, Moon YH, Bang IS, Kim YC, Kim SA, Ahn SG and Yoon JH: Antimicrobial effect of photodynamic therapy using a highly pure chlorin e6. Lasers Med Sci 25: 705-710, 2010.
11. Dai T, Huang YY and Hamblin MR: Photodynamic therapy for localized infections - state of the art. Photodiagnosis Photodyn Ther 6: 170-188, 2009.
12. Huang L, Dai T and Hamblin MR: Antimicrobial photodynamic inactivation and photodynamic therapy for infections. Methods Mol Biol 635: 155-173, 2010.
13. Malik R, Manocha A and Suresh DK: Photodynamic therapy - A strategic review. Indian J Dent Res 21: 285-291, 2010.
14. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
15. 15N) nitrate in biological fluids. Anal Biochem 126: 131-138, 1982. (Pubitemid 13203451)
16. Czuba ZP, Król W, Hasiński P and Nowowiejska A: The effects of taxol (paclitaxel) on chemiluminescence of neutrophils, macrophages and J774.2 cell line. Acta Biochim Pol 45: 103-106, 1998. (Pubitemid 128646348)
17. Coutier SL, Bezdetnaya S, Marchal V, Melnikoval, Belitchenko J, Merlin L and Guillemin F: Foscan (mTHPC) photosensitized macrophage activation: en hancement of phagocytosis, nitric oxide release and TNF-α mediated cytolytic activity. Br J Cancer 81: 37-42, 1999.
18. Gollnik SO, Liu X, Owczarczak B, Musser DA and Henderson BW: Altered expression of interleukin 6 and interieukin 10 as a result of photodynamic therapy in vivo. Cancer Res 57: 3904-3909, 1997 (Pubitemid 27427673)
19. Kawczyk-Krupka A, Wiczkowski A, Adamek M and Sieron A: Photodynamic therapy and its immunomodulating activity in malignant skin tumors and oral leukoplakia. Acta Bio-Opt Inf Med 7: 67-72, 2001.
20. Vidal-Vanaclocha F, Fantuzzi G, Mendoza L, Fuentes AM, Anasagasti MJ, Martin J, Carrascal T, Walsh P, Reznikov LL, Novick D, Rubinstein M and Dinarello CA: IL-18 regulates IL-1-beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule. Proc Natl Acad Sci USA 97: 734-739, 2000. (Pubitemid 30070378)
21. Back SH, Ohgi KA, Rose DW, Koo EH, Glass CK and Rosenfeld MG: Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappa-B and beta-amyloid precursor protein. Cell 110: 55-67, 2002. (Pubitemid 34874606)
22. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA and Apte RN: IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100: 2645-2650, 2003. (Pubitemid 36297552)
23. De Vree, WJ, Essers MC, Koster JF and Sluiter W: Role of interieukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res 57: 2555-2558, 1997. (Pubitemid 27283755)
24. Boehncke WH, Konig K, Kaufmann R, Scheffold W, Prummer O and Sterry W: Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch Dermatol Res 286: 300-303, 1994. (Pubitemid 24223609)
25. Chen G and Goeddel DV: TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635, 2002. (Pubitemid 34579145)
26. Kick G, Messer G, Plewig G, Kind P and Goetz AE: Strong and prolonged induction of c-jun and c-fos protooncogenes by photodynamic therapy. Br J Cancer 74: 30-36, 1996. (Pubitemid 26231974)
27. De Rojas-Walker T, Tamir S, Ji H, Wshnok JS and Tannenbaum SR: Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem Res Toxicol 8: 473-477, 1995.
28. Gomes ER, Almeida RD, Carvalho AP and Duarte CB: Nitric oxide modulates tumor cell death induced by photodynamic therapy through a cGMP-dependent mechanism. Photochem Photobiol 76: 423-430, 2002.
29. Castano AP, Mroz P and Hamblin MR: Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6: 535-545, 2006.
30. Oseroff A: PDT as a cytotoxic agent and biological response modifier: Implications for cancer prevention and treatment in immuno suppressed and immunocompetent patients. J Invest Dermatol 126: 542-544, 2006.
31. Koide N, Nishio A, Sato T, Sugiyama A and Miyagawa S: Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol 99: 1667-1674, 2004 (Pubitemid 39237489)
32. Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N and Nomura Y: Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 7: 263-269, 2000. (Pubitemid 30440592)
33. Lissbrant IF, Stattin P, Wikstrom P, Damber JE, Egevad L and Bergh A: Tumor associated macrophages in human prostate cancer: Relation to clinicopathological variables and survival. Int J Oncol 17: 445-451, 2000.
34. Ohno S, Ohno Y, Suzuki N, Kamei T, Koike K, Inagawa H, Kohchi C, Soma G and Inoue M: Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res 24: 3335-3342, 2004. (Pubitemid 39390949)
35. Leek RD, Landers RJ, Harris AL and Lewis CE: Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79: 991-995, 1999. (Pubitemid 29082138)
36. Casas A, di Venosa G, Vanzulli S, Perotti C, Mamome L, Rodriguez L, Simian M, Juarranz A, Pontiggia O, Hassan T and Battle A: Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photo dynamic therapy. Cancer Lett 271: 342-351, 2008.